PainReform Ltd.
PRFX
$2.44
$0.125.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -10.45% | -4.00% | -32.41% | -14.45% | -37.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -75.27% | -34.80% | 226.15% | 130.34% | 9.46% |
| Operating Income | 75.27% | 34.80% | -226.15% | -130.34% | -9.46% |
| Income Before Tax | 81.96% | -2,547.22% | -235.26% | -138.56% | -54.67% |
| Income Tax Expenses | -50.00% | -- | -- | -- | -11.11% |
| Earnings from Continuing Operations | 81.91% | -2,558.33% | -235.26% | -138.56% | -54.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.91% | -2,558.33% | -235.26% | -138.56% | -54.49% |
| EBIT | 75.27% | 34.80% | -226.15% | -130.34% | -9.46% |
| EBITDA | 75.34% | 34.95% | -226.56% | -130.36% | -9.48% |
| EPS Basic | 99.20% | -203.33% | -5.41% | -28.39% | -6.40% |
| Normalized Basic EPS | 99.20% | -202.86% | -5.41% | -28.39% | -6.53% |
| EPS Diluted | 99.20% | -203.33% | -5.23% | -28.39% | -6.35% |
| Normalized Diluted EPS | 99.20% | -202.86% | -5.41% | -28.39% | -6.53% |
| Average Basic Shares Outstanding | 2,149.85% | 2,280.91% | 218.28% | 85.90% | 45.01% |
| Average Diluted Shares Outstanding | 2,149.85% | 2,280.91% | 218.28% | 85.90% | 45.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |